Hypoxia induces RANK and RANKL expression by activating HIF-1α in breast cancer cells
- 13 May 2011
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 408 (3), 411-416
- https://doi.org/10.1016/j.bbrc.2011.04.035
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signallingNature, 2011
- A novel binding protein of single immunoglobulin IL-1 receptor-related molecule: Paralemmin-3Biochemical and Biophysical Research Communications, 2011
- RANKL increases migration of human lung cancer cells through intercellular adhesion molecule‐1 up‐regulationJournal of Cellular Biochemistry, 2010
- Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancerNature, 2010
- Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasionBritish Journal of Cancer, 2009
- Regulation of cancer cell migration and bone metastasis by RANKLNature, 2006
- Signalling hypoxia by HIF hydroxylasesBiochemical and Biophysical Research Communications, 2005
- Receptor Activator of NF-κB Ligand Induction via Jak2 and Stat5a in Mammary Epithelial CellsOnline Journal of Public Health Informatics, 2003
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- A New Member of Tumor Necrosis Factor Ligand Family, ODF/OPGL/TRANCE/RANKL, Regulates Osteoclast Differentiation and FunctionBiochemical and Biophysical Research Communications, 1999